PacBio Announces Third Quarter 2021 Financial Results
November 02, 2021 16:05 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2021. Record revenue reflects 6th straight quarter...
PacBio’s Sequel IIe Selected by Prenetics to Build Personalized Genomics for Healthcare
November 02, 2021 16:03 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif. and HONG KONG, Nov. 02, 2021 (GLOBE NEWSWIRE) -- PacBio will be providing its high-quality, highly accurate sequencing platforms to Prenetics Group Limited, a leading global...
Pacific Biosciences of California, Inc. Third Quarter 2021 Financial Results Call
October 19, 2021 16:05 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its third quarter 2021 financial...
PacBio Partners with The European Reference Genome Atlas Initiative
September 27, 2021 09:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, highly accurate...
Pacific Biosciences Grants Equity Incentive Award to New Employee
September 24, 2021 16:05 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing...
Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence
September 20, 2021 16:05 ET
|
Pacific Biosciences of California, Inc.
Omniome’s high accuracy short-read sequencing platform expected to significantly expand PacBio’s market opportunity Acquisition expected to accelerate the adoption of SMRT Sequencing, PacBio’s...
Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences
September 03, 2021 09:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor...
Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conference
August 09, 2021 08:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor...
Pacific Biosciences of California, Inc. Announces Second Quarter 2021 Financial Results
August 03, 2021 16:05 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2021. Record second...
Pacific Biosciences Acquires Circulomics – A Leading High Molecular Weight DNA Extraction Company
August 03, 2021 08:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read...